Although the journal Applied Clinical Trials started reporting on patient centricity in 2014, there is still no universally accepted definition of a patient-centric trial and no standardized way to determine whether a protocol design is optimal for patients. Lacking those tools, many sponsors struggle to design and conduct studies that accommodate the perspectives and preferences of patients and caregivers.

Ideally, there should be a consistent gold-standard methodology to embed patient centricity into the software we build to run clinical research. We call our process Patient Centricity by Design (PCbD), a spin on the concept of privacy by design (PbD) developed by IT pioneer Ann Cavoukian. Complete the form to access our white paper which details this ground-breaking new program, and how it can advance the science of clinical research and bring new therapies more quickly to those who need them.